Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Armata Pharmaceuticals (ARMP) Invested Capital (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Invested Capital for 6 consecutive years, with $8.8 million as the latest value for Q3 2018.

  • Quarterly Invested Capital fell 9.85% to $8.8 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $8.8 million through Sep 2018, down 9.85% year-over-year, with the annual reading at $24.3 million for FY2017, 150.37% up from the prior year.
  • Invested Capital hit $8.8 million in Q3 2018 for Armata Pharmaceuticals, down from $11.6 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $24.3 million in Q4 2017 to a low of -$34.0 million in Q1 2014.
  • Historically, Invested Capital has averaged $7.3 million across 5 years, with a median of $9.8 million in 2017.
  • Biggest five-year swings in Invested Capital: soared 389.24% in 2016 and later crashed 54.1% in 2017.
  • Year by year, Invested Capital stood at $3.4 million in 2014, then skyrocketed by 269.92% to $12.7 million in 2015, then decreased by 23.53% to $9.7 million in 2016, then skyrocketed by 150.37% to $24.3 million in 2017, then tumbled by 63.87% to $8.8 million in 2018.
  • Business Quant data shows Invested Capital for ARMP at $8.8 million in Q3 2018, $11.6 million in Q2 2018, and $14.7 million in Q1 2018.